{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:58:57Z","timestamp":1774965537799,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["S10OD030403"],"award-info":[{"award-number":["S10OD030403"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA091842"],"award-info":[{"award-number":["P30 CA091842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["S10OD018515"],"award-info":[{"award-number":["S10OD018515"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA291680"],"award-info":[{"award-number":["R21 CA291680"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R37CA276498"],"award-info":[{"award-number":["R37CA276498"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["EB025815"],"award-info":[{"award-number":["EB025815"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University in St Louis School of Medicine","doi-asserted-by":"publisher","award":["P30 CA091842"],"award-info":[{"award-number":["P30 CA091842"]}],"id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University in St Louis School of Medicine","doi-asserted-by":"publisher","award":["fluorine-18"],"award-info":[{"award-number":["fluorine-18"]}],"id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University in St Louis School of Medicine","doi-asserted-by":"publisher","award":["R37CA276498"],"award-info":[{"award-number":["R37CA276498"]}],"id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University in St Louis School of Medicine","doi-asserted-by":"publisher","award":["S10OD018515"],"award-info":[{"award-number":["S10OD018515"]}],"id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University in St Louis School of Medicine","doi-asserted-by":"publisher","award":["S10OD030403"],"award-info":[{"award-number":["S10OD030403"]}],"id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023938","name":"Mallinckrodt Institute of Radiology, School of Medicine, Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006442","name":"Center for Drug Discovery, Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS134586"],"award-info":[{"award-number":["NS134586"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS103988"],"award-info":[{"award-number":["NS103988"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nucmedbio.2025.109057","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:02:19Z","timestamp":1754582539000},"page":"109057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Imaging and targeting S1PR1 in HER2+ tumors"],"prefix":"10.1016","volume":"148-149","author":[{"given":"Shayla","family":"Shmuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Vanover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia M.R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109057_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"10.1016\/j.nucmedbio.2025.109057_bb0010","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.12998\/wjcc.v7.i15.1964","article-title":"HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer","volume":"7","author":"Kaito","year":"2019","journal-title":"World J Clin Cases"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109057_bb0015","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s10120-022-01298-6","article-title":"Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab","volume":"25","author":"Bang","year":"2022","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-019-0737-2","article-title":"Progress and challenges in HER2-positive gastroesophageal adenocarcinoma","volume":"12","author":"Zhao","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.nucmedbio.2025.109057_bb0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41571-021-00492-2","article-title":"Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm","volume":"18","author":"Nakamura","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109057_bb0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41571-024-00924-9","article-title":"HER2-targeted therapies beyond breast cancer - an update","volume":"21","author":"Yoon","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109057_bb0040","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41591-024-02992-x","article-title":"Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial","volume":"30","author":"Shitara","year":"2024","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.nucmedbio.2025.109057_bb0045","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S1470-2045(17)30604-6","article-title":"Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study","volume":"18","author":"Doi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109057_bb0050","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(17)30111-0","article-title":"Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2\/3 study","volume":"18","author":"Thuss-Patience","year":"2017","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.nucmedbio.2025.109057_bb0055","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1200\/JCO.2013.53.6136","article-title":"Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study","volume":"32","author":"Satoh","year":"2014","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109057_bb0060","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S1470-2045(18)30481-9","article-title":"Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study","volume":"19","author":"Tabernero","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109057_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109057_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2875","article-title":"Sphingosine 1-phosphate and cancer","volume":"10","author":"Pyne","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s13046-019-1369-7","article-title":"S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway","volume":"38","author":"Liu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2025.109057_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2018.10.005","article-title":"S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation","volume":"37","author":"Song","year":"2018","journal-title":"EBioMedicine"},{"issue":"46","key":"10.1016\/j.nucmedbio.2025.109057_bb0095","doi-asserted-by":"crossref","first-page":"35957","DOI":"10.1074\/jbc.M110.117945","article-title":"Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1\/2 in MDA-MB-453 breast cancer cells","volume":"285","author":"Long","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109057_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbrc.2004.12.088","article-title":"Lysophospholipids transactivate HER2\/neu (erbB-2) in human gastric cancer cells","volume":"327","author":"Shida","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.nucmedbio.2025.109057_bb0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109057_bb0110","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11307-016-0944-y","article-title":"PET imaging study of S1PR1 expression in a rat model of multiple sclerosis","volume":"18","author":"Liu","year":"2016","journal-title":"Mol Imaging Biol"},{"issue":"19","key":"10.1016\/j.nucmedbio.2025.109057_bb0115","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/acschemneuro.1c00492","article-title":"In vitro and in vivo investigation of S1PR1 expression in the central nervous system using [3H]CS1P1 and [11C]CS1P1","volume":"12","author":"Jiang","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"10.1016\/j.nucmedbio.2025.109057_bb0120","first-page":"1775","article-title":"Phase 1 evaluation of 11C-CS1P1 to assess safety and dosimetry in human participants","volume":"63","author":"Brier","year":"2022","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109057_bb0125","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/D1OB02225C","article-title":"Radiosynthesis and evaluation of a fluorine-18 radiotracer [18F]FS1P1 for imaging sphingosine-1-phosphate receptor 1","volume":"20","author":"Qiu","year":"2022","journal-title":"Org Biomol Chem"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109057_bb0130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/D1OB02225C","article-title":"Radiosynthesis and evaluation of a fluorine-18 radiotracer 18F-FS1P1 for imaging sphingosine-1-phosphate receptor 1","volume":"20","author":"Qiu","year":"2022","journal-title":"Org Biomol Chem"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0135","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1038\/s41467-022-30142-9","article-title":"Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer","volume":"13","author":"Pereira","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2025.109057_bb0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.apradiso.2019.06.029","article-title":"Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [11C]CS1P1 for human use","volume":"152","author":"Luo","year":"2019","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109057_bb0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12350-015-0391-1","article-title":"A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury","volume":"24","author":"Jin","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109057_bb0150","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1038\/s41467-018-07608-w","article-title":"Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy","volume":"9","author":"Pereira","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2025.109057_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660842","article-title":"A novel radioimmune 99mTc-labeled tracer for imaging sphingosine 1-phosphate receptor 1 in tumor xenografts: an in vitro and in vivo study","volume":"12","author":"Ye","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109057_bb0160","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.celrep.2014.02.016","article-title":"S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3","volume":"6","author":"Priceman","year":"2014","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109057_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.16","article-title":"The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERalpha expression and enhances hormonal therapy for breast cancer","volume":"4","author":"Hait","year":"2015","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109057_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41419-018-1298-y","article-title":"Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109057_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103679","article-title":"HER2-low gastric cancer: is the subgroup targetable?","volume":"9","author":"Shimozaki","year":"2024","journal-title":"ESMO Open"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:11:32Z","timestamp":1774962692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"alternative-id":["S0969805125000666"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109057","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging and targeting S1PR1 in HER2+ tumors","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109057"}}